Our CEO Chris Davison was incredibly happy to be a part of an expert panel talking with South East Business Insider Magazine. Alongside other industry experts Chris was asked to comment on the current ‘business health’ of the Life Sciences industry and to help shed some light on the challenges and opportunities it faces.
Chris was able to talk passionately about the issues that are directly facing Custom Pharma Services and the biotech landscape as a whole including the effect of the upheavals in global supply chains, the support offered for innovation within Life Sciences, ESG funding and investment and the impact of AI going forward. If you want to read more you can view the article here.
